BJDX — Bluejay Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Bluejay Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	19	10.1	2.21	4.3	5.16
Net Total Accounts Receivable
Net Total Receivables	0	—	—	—	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	20.7	11.8	3.22	4.9	5.46
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.337	1.7	1.62	1.72	1.65
Other Long Term Assets
Total Assets	21	13.5	4.87	6.66	7.12
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.637	1.64	1.77	0.81	1.12
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.637	1.98	1.97	0.928	1.14
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	20.4	11.5	2.89	5.73	5.98
Total Liabilities & Shareholders' Equity	21	13.5	4.87	6.66	7.12
Total Common Shares Outstanding